ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 126 filers reported holding ANAPTYSBIO INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $10,000,000 | +2773.6% | 203 | -98.0% | 0.10% | +33.3% |
| Q1 2022 | $348,000 | 0.0% | 10,000 | 0.0% | 0.08% | 0.0% |
| Q4 2021 | $348,000 | +28.4% | 10,000 | 0.0% | 0.08% | +20.0% |
| Q3 2021 | $271,000 | +4.6% | 10,000 | 0.0% | 0.06% | -4.4% |
| Q2 2021 | $259,000 | +19.9% | 10,000 | 0.0% | 0.07% | +19.3% |
| Q1 2021 | $216,000 | +0.5% | 10,000 | 0.0% | 0.06% | -3.4% |
| Q4 2020 | $215,000 | +45.3% | 10,000 | 0.0% | 0.06% | +22.9% |
| Q3 2020 | $148,000 | -34.8% | 10,000 | 0.0% | 0.05% | -36.0% |
| Q2 2020 | $227,000 | +62.1% | 10,000 | 0.0% | 0.08% | +17.2% |
| Q1 2020 | $140,000 | -14.1% | 10,000 | 0.0% | 0.06% | +8.5% |
| Q4 2019 | $163,000 | -53.4% | 10,000 | 0.0% | 0.06% | -63.6% |
| Q3 2019 | $350,000 | -60.5% | 10,000 | +17.6% | 0.16% | -53.0% |
| Q1 2018 | $885,000 | -48.3% | 8,500 | -50.0% | 0.34% | -42.8% |
| Q4 2017 | $1,711,000 | -38.7% | 17,000 | -83.1% | 0.60% | -43.5% |
| Q1 2017 | $2,789,000 | – | 100,500 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |